Ramsay Générale de (GDS) | Stock Overview & Key Data
Ramsay Générale de Santé S.A. | Large-cap | Healthcare
Ramsay Générale de Santé S.A. | Large-cap | Healthcare
Ramsay Générale de Performance Comparison
Stock Range
Today's Range
Low: €10.10
High: €10.20
on August 8, 2025
52 Week Range
Low: €9.46
High: €15.95
on April 29, 2025
on September 5, 2024
All-Time High: €26.10 on June 6, 2022
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€1.1B
EPS
-0.72
P/E Ratio (TTM)
34.13
Forward P/E
N/A
P/B Ratio
0.98
PEG Ratio
-0.16
Div. Yield
N/A
ROE
-5.16%
Beta
0.193
Debt to Equity
337.92
Financial Highlights
Profitability
Gross Margin
71.87%
Operating Margin
2.41%
Profit Margin
-1.55%
Returns and Earnings
Return on Assets (TTM)
1.48%
Return on Equity (TTM)
-5.16%
EBITDA
€215.4M
Net Income (TTM)
€-79.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€46.61
Quarterly Revenue Growth (YoY)
5.80%
Quarterly Earnings Growth (YoY)
-33.60%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Ramsay Générale de GDS | 1.11B Large-cap | -3.81% | -8.18% | 6.32% | 1.41% | -21.09% | -32.21% | -51.44% | -41.62% |
| Emeis S.A EMEIS | 2.11B Large-cap | -4.99% | 13.58% | 16.03% | 64.89% | 113.16% | 32.52% | -99.21% | -99.81% |
| Orpea ORP | 1.96B Mid-cap | -4.99% | 13.58% | 16.03% | 64.89% | 113.16% | 30.88% | -99.22% | -99.81% |
| Clariene SE CLARI | 1.56B Large-cap | -1.97% | -14.37% | 19.20% | 72.59% | 107.91% | 137.77% | -41.57% | -41.57% |
| Lna Santé S.A LNA | 286.31M Mid-cap | 10.53% | 20.69% | 32.35% | 28.57% | 30.98% | 26.34% | -8.90% | -39.92% |
| EssilorLuxottica EL | 117.98B Large-cap | -3.22% | 6.46% | 3.49% | -6.56% | 7.69% | 20.96% | 54.82% | 129.38% |
Ownership & Short Interest
Insider Ownership
59.38%
Institutional Ownership
39.92%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
399
Average 90-Day Volume
307
Ramsay Générale de Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Ramsay Générale de would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GDS's 52-week high and low?
- In the last 52 weeks, Ramsay Générale de reached a high of €15.95 (on September 5, 2024) and a low of €9.46 (on April 29, 2025).
- What is the market cap and P/E ratio for GDS?
- Curious about Ramsay Générale de's size and valuation? Its market capitalization stands at 1.11B. When it comes to valuation, the P/E ratio (trailing twelve months) is 34.13, and the forward P/E (looking ahead) is N/A.
- Does GDS pay dividends? If so, what's the yield?
- As for dividends, Ramsay Générale de isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Ramsay Générale de's main competitors or similar companies to consider before investing?
When looking at Ramsay Générale de, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Emeis S.A
EMEIS2.11B Healthcare Medical Care Facilities 32.52% -99.21% Orpea
ORP1.96B Healthcare Medical Care Facilities 30.88% -99.22% Clariene SE
CLARI1.56B Healthcare Medical Care Facilities 137.77% -41.57% Lna Santé S.A
LNA286.31M Healthcare Medical Care Facilities 26.34% -8.90% EssilorLuxottica
EL117.98B Healthcare Medical Instruments & Supplies 20.96% 54.82% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ramsay Générale de Santé S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Ramsay Générale de's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -5.16%, the Debt to Equity ratio from the most recent quarter is 337.92, and its Gross Profit Margin stands at 71.87%.
- What is the recent revenue and earnings growth for GDS?
- Looking at Ramsay Générale de's growth, its revenue over the trailing twelve months (TTM) was €5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.80%, and quarterly earnings saw a YoY growth of -33.60%.
- How much of GDS stock is held by insiders and institutions?
- Wondering who owns Ramsay Générale de stock? Company insiders (like executives and directors) hold about 59.38% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 39.92%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.